EwelinaKMamcarzMD

Pediatric Hematology & Oncology • Memphis, TN

Physician

Join to view full profile

Dr. Mamcarz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mamcarz's full profile

Already have an account?

Office
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105

Education & Training

Children's National Hospital/George Washington UniversityFellowship, Pediatric Hematology/Oncology, 2010 - 2013
Marshfield ClinicResidency, Pediatrics, 2007 - 2010
Medical University of SilesiaClass of 2003

Certifications & Licensure

TN State Medical License 2014 - 2025
DC State Medical License 2010 - 2014
WI State Medical License 2008 - 2011
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants Start of enrollment: 2016 Aug 17
Suspended
Phase 1, Phase 2
Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID) Start of enrollment: 2021 Sep 02
Active, not recruiting
Phase 1, Phase 2

Publications & Presentations

PubMed

Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial.
Swati Naik, Ying Li, Aimee C Talleur, Subodh Selukar, Emily Ashcraft
Journal of Hematology & Oncology. 2024-06-27
Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hemat...
Rebecca Epperly, Ying Li, Subodh Selukar, Emily Zeng, Renee Madden
Transplantation and Cellular Therapy. 2024-05-01
2 citations
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II intervent...
Michael D Keller, Patrick J Hanley, Yueh-Yun Chi, Paibel Aguayo-Hiraldo, Christopher C Dvorak
Nature Communications. 2024-04-18

Journal Articles

Selective T‐Cell Depletion Targeting CD45RA Reduces Viremia and Enhances Early T‐Cell Recovery Compared with CD3‐Targeted T‐Cell Depletion
Brandon M Triplett, David R Shook, Ewelina Mamcarz, Randall T Hayden, Shane J Cross, Ashok Srinivasan, Transplant Infectious Disease

Abstracts/Posters

Enhanced Transduction Lentivector Gene Therapy for Treatment of Older Patients with X-Linked Severe Combined Immunodeficiency
Ewelina Mamcarz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Lentiviral Gene Therapy with Low Dose Busulfan for Infants with X-SCID Results in the Development of a Functional Normal Immune System: Interim Results of an Ongoing P...
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

Updates on Gene Therapy for ‘Bubble Boy’ Disease and Cellular Immunotherapy at ASGCTMay 12th, 2022
The Quest to Overcome Gene Therapy’s FailuresOctober 18th, 2021
Mustang Bio Announces Additional Clinical Data on MB-107December 9th, 2019
Join now to see all